The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
From MaRDI portal
Publication:1889366
DOI10.1007/S00285-003-0246-2zbMATH Open1063.92029OpenAlexW2013329924WikidataQ40521314 ScholiaQ40521314MaRDI QIDQ1889366FDOQ1889366
Publication date: 1 December 2004
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s00285-003-0246-2
Cited In (9)
- Title not available (Why is that?)
- Overcoming drug resistance to BRAF inhibitor
- Spatial invasion dynamics on random and unstructured meshes: implications for heterogeneous tumor populations
- Analysis of resonance chemotherapy in leukemia treatment via multi-staged population balance models
- Optimal therapy scheduling based on a pair of collaterally sensitive drugs
- Modelling chemotherapy resistance in palliation and failed cure
- A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma
- Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
- Stochastic modeling of drug resistance in cancer
Recommendations
- The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics 👍 👎
- Mathematical model of cancer chemotherapy. Periodic schedules of phase- specific cytotoxic-agent administration increasing the selectivity of therapy 👍 👎
- Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution 👍 👎
- The worst drug rule revisited: mathematical modeling of cyclic cancer treatments 👍 👎
- Title not available (Why is that?) 👍 👎
This page was built for publication: The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1889366)
